awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28534786-0FAE07E1-D16C-4839-8C6E-55FF6A0416B6
Q28534786-0FAE07E1-D16C-4839-8C6E-55FF6A0416B6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28534786-0FAE07E1-D16C-4839-8C6E-55FF6A0416B6
Ixabepilone administered weekly or every three weeks in HER2-negative metastatic breast cancer patients; a randomized non-comparative phase II trial
P2860
Q28534786-0FAE07E1-D16C-4839-8C6E-55FF6A0416B6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28534786-0FAE07E1-D16C-4839-8C6E-55FF6A0416B6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
853015b46ac932dfea0fb06e92905d63325fe7e2
P2860
Chemotherapy resistance in metastatic breast cancer: the evolving role of ixabepilone